A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas – a study within the Central... von Mross, K, Dittrich, C, Aulitzky, W E, Strumberg, D, Schutte, J, Schmid, R M, Hollerbach, S, Merger, M, Munzert, G, Fleischer, F, Scheulen, M E

Volltext

RITA can induce cell death in p53-defective cells independently of p53 function via activation of JNK/SAPK and p38 von Weilbacher, A, Gutekunst, M, Oren, M, Aulitzky, W E, van der Kuip, H

Volltext

A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticanc... von Bergmann, L, Maute, L, Heil, G, Rüssel, J, Weidmann, E, Köberle, D, Fuxius, S, Weigang-Köhler, K, Aulitzky, W E, Wörmann, B, Hartung, G, Moritz, B, Edler, L, Burkholder, I, Scheulen, M E, Richly, H

Volltext

Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial von Schetelig, J, Schaich, M, Schäfer-Eckart, K, Hänel, M, Aulitzky, W E, Einsele, H, Schmitz, N, Rösler, W, Stelljes, M, Baldus, C D, Ho, A D, Neubauer, A, Serve, H, Mayer, J, Berdel, W E, Mohr, B, Oelschlägel, U, Parmentier, S, Röllig, C, Kramer, M, Platzbecker, U, Illmer, T, Thiede, C, Bornhäuser, M, Ehninger, G

Volltext

Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma von METZGEROTH, G, WALZ, C, MÜLLER, M. C, BENEKE, H, MÜLLER, L, DEL VALLE, F, AULITZKY, W. E, WITTKOWSKY, G, SCHMITZ, N, SCHULTE, C, MULLER-HERMELINK, K, HODGES, E, SCORE, J, WHITTAKER, S. J, DIECKER, F, DÖHNER, H, SCHULD, P, HEHLMANN, R, HOCHHAUS, A, CROSS, N. C. P, REITER, A, SIEBERT, R, SCHNITTGER, S, HAFERLACH, C, POPP, H, HAFERLACH, T, ERBEN, P, MIX, J

Volltext

Discrepant NOXA (PMAIP1) transcript and NOXA protein levels: a potential Achilles’ heel in mantle cell lymphoma von Dengler, M A, Weilbacher, A, Gutekunst, M, Staiger, A M, Vöhringer, M C, Horn, H, Ott, G, Aulitzky, W E, van der Kuip, H

Volltext

Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutations von Heidrich, K, Thiede, C, Schäfer-Eckart, K, Schmitz, N, Aulitzky, W E, Krämer, A, Rösler, W, Hänel, M, Einsele, H, Baldus, C D, Trappe, R U, Stölzel, F, Middeke, J M, Röllig, C, Taube, F, Kramer, M, Serve, H, Berdel, W E, Ehninger, G, Bornhäuser, M, Schetelig, J

Volltext

Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial von Stölzel, F, Pfirrmann, M, Aulitzky, W E, Kaufmann, M, Bodenstein, H, Bornhäuser, M, Röllig, C, Kramer, M, Mohr, B, Oelschlägel, U, Schmitz, N, Soucek, S, Thiede, C, Ehninger, G, Schaich, M

Volltext

Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML—long-term results of a prospective randomized intergroup study of the East German Study Grou... von Thiel, A., Schetelig, J., Pönisch, W., Schäfer-Eckart, K., Aulitzky, W., Peter, N., Schulze, A., Maschmeyer, G., Neugebauer, S., Herbst, R., Hänel, A., Morgner, A., Kroschinsky, F., Bornhäuser, M., Lange, T., Wilhelm, M., Niederwieser, D., Ehninger, G., Fiedler, F., Hänel, M.

Volltext

Sequential high dose chemotherapy as initial treatment for aggressive sub-types of Non-Hodgkin Lymphoma: results of the international randomized phase III trial (MISTRAL) von Betticher, DC, Martinelli, G, Radford, JA, Kaufmann, M, Dyer, MJS, Kaiser, U, Aulitzky, WE, Beck, J, von Rohr, A, Kovascovics, T, Cogliatti, SB, Cina, S, Maibach, R, Cerny, T, Linch, DC

Volltext

Pharmacological inhibition of c-Abl compromises genetic stability and DNA repair in Bcr-Abl-negative cells von Fanta, S, Sonnenberg, M, Skorta, I, Duyster, J, Miething, C, Aulitzky, W E, van der Kuip, H

Volltext

Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study von Paulussen, M., Ahrens, S., Lehnert, M., Taeger, D., Hense, H. W., Wagner, A., Dunst, J., Harms, D., Reiter, A., Henze, G., Niemeyer, C., Göbel, U., Kremens, B., Fölsch, U. R., Aulitzky, W. E., A.Voûte, P., Zoubek, A., Jürgens, H.

Volltext

Bcr-Abl kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell lines von Jonuleit, Tarja, van der Kuip, Heiko, Miething, Cornelius, Michels, Heike, Hallek, Michael, Duyster, Justus, Aulitzky, Walter E.

Volltext

PO-303 Modified P53 functionality in cancer-associated fibroblasts promotes cancer growth von Arundkar, SC, Furth, N, Elisha, Y, Nataraj, N, Kuip, HVD, Aulitzky, W, Ulitsky, I, Geiger, B, Oren, M

Volltext

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia von Hochhaus, Andreas, Larson, Richard A, Guilhot, François, Radich, Jerald P, Branford, Susan, Hughes, Timothy P, Baccarani, Michele, Deininger, Michael W, Cervantes, Francisco, Fujihara, Satoko, Ortmann, Christine-Elke, Menssen, Hans D, Kantarjian, Hagop, O’Brien, Stephen G, Druker, Brian J

Volltext

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C von MÜLLER, M. C, GATTERMANN, N, KRAUSE, S. W, NERL, C, SAYER, H. G, OTTMANN, O. G, WALLER, C, AULITZKY, W, LE COUTRE, P, FREUND, M, MERX, K, PASCHKA, P, LAHAYE, T, KÖNIG, H, KREIL, S, BERGER, U, GSCHAIDMEIER, H, HEHLMANN, R, HOCHHAUS, A, DEININGER, M. W. N, BERNDT, A, FRUEHAUF, S, NEUHAUER, A, FISCHER, T, HOSSFELD, D. K, SCHNELLER, F

Volltext

Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation von KOLBE, K, DOMKIN, D, DERIGS, H. G, BHAKDI, S, HUBER, C, AULITZKY, W. E

Volltext

Successful antiviral treatment for fulminant reactivated hepatitis B after autologous stem cell transplantation and prophylaxis during subsequent allogeneic stem cell transplantati... von HENKES, M, MARTIN, S, EINSELE, H, AULITZKY, W. E

Volltext

Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer von Swain, Sandra M, Baselga, José, Kim, Sung-Bae, Ro, Jungsil, Semiglazov, Vladimir, Campone, Mario, Ciruelos, Eva, Ferrero, Jean-Marc, Schneeweiss, Andreas, Heeson, Sarah, Clark, Emma, Ross, Graham, Benyunes, Mark C, Cortés, Javier

Volltext

Role of poly(ADP-ribose) polymerase activity in imatinib mesylate-induced cell death von Moehring, A, Wohlbold, L, Aulitzky, W E, van der Kuip, H

Volltext